Application of dicarbamin in treatment of patients by a chronic hepatitis C

QR Code

Application of dicarbamin in treatment of patients by a chronic hepatitis C

Aim of investigation. Studying of clinical and laboratory efficacy of dicarbamin as hematoprotector in patients with chronic hepatitis C (CHC) with 1b virus genotype at combined antiviral therapy (AVT) by pegilated interferons in combination to ribavirin.Material and methods. Overall 110 patients wi...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. Yu. Konstantinov, Ye. A. Konstantinova, L. L. Popova, E. A. Strebkova, A. A. Suzdaltsev
Format:	Article
Language:	Russian
Published:	Gastro LLC 2011-09-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	chronic viral hepatitis c antiviral therapy dicarbamin neutropenia leukopenia
Online Access:	https://www.gastro-j.ru/jour/article/view/1451
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Leukopenia and neutropenia in chronic hepatitis C patients with various underlying combination antiviral therapy
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C
by: I. A. Narkevich, et al.
Published: (2024-02-01)

MATHEMATICAL MODELS PREDICTING LEUKOPENIA AND NEUTROPENIA IN PATIENTS WITH CHRONIC HEPATITIS C IN THE BACKGROUND INTERFERONCONTAINING SCHEMES
by: I. G. Bakulin, et al.
Published: (2016-10-01)

Planning a clinical trial programme for direct-acting antivirals for chronic viral hepatitis C
by: A. I. Gubenko, et al.
Published: (2023-12-01)

Clinical and epidemiological characteristic of chronic hepatitis C in the republic of Tyva
by: A. A. Saryglar, et al.
Published: (2023-04-01)

Clinico-laboratory and immunological characteristics of patients with compensated cirrhosis of the liver in the outcome of chronic hepatitis C on the background of treatment with a direct antiviral drug paritrapeprir/ritonavir/ombitasvir/ dasabuvir
by: L. L. Popova, et al.
Published: (2018-12-01)

Effects of antiviral therapy on reducing the risk of metabolic syndrome in patients with chronic hepatitis C
by: A. F. Novikova, et al.
Published: (2023-07-01)

The prognostic value of ferritinemia level in patients with chronic hepatitis C
by: N. C. Sargsyants, et al.
Published: (2013-07-01)

Effectiveness of antiviral treatment of patients with chronic hepatitis C GT 1b depending on the presence of comorbid chronic renal insufficiency
by: H. V. Venytska, et al.
Published: (2022-12-01)

Effectiveness of combined antyviral therapy in children with chronic hepatitis C
by: G. P. Martynova, et al.
Published: (2014-09-01)

EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2017-01-01)

Liver injury under chronic viral hepatitis C against the background of opiomania: morphological characters
by: Ye. V. Beloborodova, et al.
Published: (2011-02-01)

Chronic hepatitis C course at elderly and therapeutic approach
by: M. V. Mayevskaya, et al.
Published: (2011-02-01)

Effectiveness and safety of narlaprevir in real clinical practice of chronic hepatitis C
by: V. V. Basina, et al.
Published: (2019-12-01)

Successful antiviral therapy for chronic hepatitis C in a patient after surgery for hepatocellular carcinoma (a clinical observation)
by: I. G. Nikitin, et al.
Published: (2018-08-01)

Adverse Effects of Combined Antiviral Therapy of Chronic Hepatitis C Virus and Methods for It’s Correction
by: Y. M. Ambalov, et al.
Published: (2011-09-01)

Betaleukin in therapy of chronic hepatitis C
by: E. S. Romanova, et al.
Published: (2014-10-01)

Antiviral therapy for chronic hepatitis C: is there a time to change existing standards?
by: D. T. Abdurakhmanov
Published: (2009-02-01)

Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin
by: Yu. V. Lobzin, et al.
Published: (2014-09-01)

Herbal medications in the treatment of hepatitis C
by: V. T. Ivashkin, et al.
Published: (2009-06-01)

Change of the indices of the cytokine status in patients with chronic combined hepatitis B+C in a process of antiviral therapy
by: O. L. Sobolevskaya
Published: (2014-09-01)

THE ROLE OF CYTOKINE NETWORK IN HEPATOCELLULAR DAMAGE CAUSED BY СHRONIC HEPATITIS C
by: L. Ph. Skljar
Published: (2014-07-01)

RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS
by: S. V. Zhavoronok, et al.
Published: (2018-10-01)

Clinical-epidemiological and pathogenetic features of viral hepatitis C in the hemodialysis departments
by: R. N. Akalaev, et al.
Published: (2019-12-01)

Economic burden of chronic viral hepatitis C
by: R. A. Yakhina, et al.
Published: (2022-01-01)

TREATMENT OF HEPATITIS C WITHOUT INTERFERON IN PATIENTS UNDERGOING LIVER TRANSPLANTATION
by: M. Sh. Khubutia, et al.
Published: (2015-10-01)

CHANGES PROTEIN SPECTRUM OF BLOOD PLASMA, WHICH DEVELOP IN PATIENTS WITH CHRONIC HEPATITIS C AFTER AUTOHAEMOTHERAPY
by: D. V. Dontcov, et al.
Published: (2015-12-01)

Clinical and immunomorphological predictors of the adverse course of chronic hepatitis C
by: I. A. Karabak, et al.
Published: (2020-06-01)

B-cell non-Hodgkin's lymphoma in the patient with chronic hepatitis C and mixed cryoglobulinemia
by: V. S. Adonyeva, et al.
Published: (2015-03-01)

Modern approaches to the treatment of patients with chronic hepatitis B
by: S. F. Galimova, et al.
Published: (2009-06-01)

PERSONALIZED APPROACH TO TREATING CHRONIC HEPATITIS C IN CHILDREN
by: T. A. Skvortsova, et al.
Published: (2014-03-01)

Diagnostic markers of hepatic steatosis in patients with chronic viral hepatitis C
by: V. V. Tsvetkov, et al.
Published: (2023-05-01)

Minimization of Endogenous Intoxication Syndrome by Individual Choice of Drugs for Therapy of Chronic Hepatitis
by: D. K. Vasilyeva, et al.
Published: (2020-05-01)

Efficiency of Antiviral Therapy for Recurrence of Chronic Hepatitis C in Patients Undergoing Liver Transplantation
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

Modern modes of chronic hepatitis C treatment
by: V. T. Ivashkin, et al.
Published: (2012-02-01)

Modern etiotropic therapy of chronic viral hepatitis B
by: E. B. Bun'kova, et al.
Published: (2024-10-01)

Viral hepatitis B and C: similarities and difference
by: M. S. Karyagina, et al.
Published: (2021-06-01)

PREVALENCE OF SIDE EFFECTS OF INTERFERON THERAPY IN CHILDREN WITH CHRONIC VIRAL HEPATITIS C
by: T. A. Skvortsova, et al.
Published: (2013-05-01)

Cost-effectiveness of antiviral therapy in treatment-naive patients with chronic hepatitis C (genotype 1)
by: A. V. Rudakova, et al.
Published: (2017-06-01)

Сomparative morphological characteristics of activity score and fibrosis stage in chronic viral hepatitis C
by: I. L. Purlik, et al.
Published: (2010-10-01)